(Q34436363)

2 August 2017

title

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells (English)

1 reference

2 August 2017

1 reference

1 reference

7

I Vergote

1 reference

2 August 2017

M T M van Jaarsveld

1

1 reference

2 August 2017

J Helleman

2

1 reference

2 August 2017

A W M Boersma

3

1 reference

2 August 2017

P F van Kuijk

4

1 reference

2 August 2017

W F van Ijcken

5

1 reference

2 August 2017

E Despierre

6

1 reference

2 August 2017

R H J Mathijssen

8

1 reference

2 August 2017

E M J J Berns

9

1 reference

2 August 2017

J Verweij

10

1 reference

2 August 2017

J Pothof

11

1 reference

2 August 2017

E A C Wiemer

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

8 October 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

36

1 reference

2 August 2017

page(s)

4284-4293

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.433

2 August 2017

exact match

0 references

cites work

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

The biology of ovarian cancer: new opportunities for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Drug transporters of platinum-based anticancer agents and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Mechanisms of resistance to cisplatin and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA expression profiles for the NCI-60 cancer cell panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Clinical trials in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Treatment issues in clear cell carcinoma of the ovary: a different entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Cloning and characterization of human polyamine-modulated factor-1, a transcriptional cofactor that regulates the transcription of the spermidine/spermine N(1)-acetyltransferase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Carcinoma matrix controls resistance to cisplatin through talin regulation of NF-kB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

Glutathione and glutathione-dependent enzymes in cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.433

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.433

1 reference

Dimensions Publication ID

2 August 2017

1032971129

0 references

1 reference